Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yingbo Xie
Observed names:
Ying-Bo Xie,
Ying-bo Xie
Institutions:
First Affiliated Hospital of Guangzhou Medical University,
Guangzhou Institute of Respiratory Health
Observed institutions:
Shandong University,
First Affiliated Hospital of Guangzhou Medical University,
Shandong Provincial Hospital,
State Key Laboratory of Respiratory Disease,
Guangzhou Institute of Respiratory Health,
Guangzhou Medical University
show all 6
ORCID:
0009-0000-7681-0147
Observed ORCID:
0009-0000-7681-0147
OpenAlex ID:
A5028551786
Analysis of the resistance profile of real-world alectinib first-line therapy in patients with ALK rearrangement-positive advanced non-small cell lung cancer using organoid technology in one case of lung cancer
2024
·
Yingbo Xie
, Yuxin Zhang
, et al.
·
Journal of Thoracic Disease
·
7
Bronchial washing fluid supernatant serves as a novel liquid biopsy specimen for genome profiling in advanced non-small cell lung cancer
2025
·
Yongqing Wu
, Yingbo Xie
, et al.
·
Lung Cancer
·
4
[Pathogenesis of liver fibrosis in patients with chronic hepatitis B].
2009
·
Jun Shi
, Jing-hua Hao
, et al.
·
PubMed
·
4
Hepatic microcirculatory disturbances in patients with chronic hepatitis B.
2002
·
Jinghua Hao
, Jun Shi
, et al.
·
PubMed
·
3
Development of clinical-radiological prediction models to prioritize ALK, ROS1, and RET fusion testing in major driver alteration-negative non-small cell lung cancer
2026
·
Yike Wang
, Yingbo Xie
, et al.
·
Journal of Thoracic Disease
·
1
Predictive modeling of peripheral blood EGFR positivity in patients with advanced primary non-small cell lung cancer
2026
·
Ying-Bo Xie
, Yi-Ke Wang
, et al.
·
Translational Lung Cancer Research
A predictive model for fusion gene positivity in treatment-naive advanced non-small cell lung cancer
2026
·
Yike Wang
, Yingbo Xie
, et al.
·
Translational Lung Cancer Research
Fine-Needle Aspiration improved the success rate of organoid generation and assists personalized-therapies for EGFR+ combined small cell lung cancer patients
2024
·
ZhanHong Xie
, Yingbo Xie
, et al.
·
European Respiratory Journal
Flushing fluid of post-bronchoscopic biopsy as a novel liquid biopsy specimen for genome profiling in advanced lung cancer.
2024
·
Zhanhong Xie
, YongQing Wu
, et al.
·
Journal of Clinical Oncology
PDF
Show more works
View as search
Works count:
9
Citation count:
19
H-index:
3
I10-index:
Year
Topic
Type